Assessment of Tubal Occlusion During Minimally Invasive Myomectomy
Recruiting
N/A
Interventional Study
Fallopian Tube Patency Tests
Fibroid/Myoma (Uterus/Cervix)
Myomectomy
Fallopian Tube Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 50 (estimated)
- Sponsor
- Medstar Health Research Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study uses a procedure called chromopertubation to look at how fibroids and fibroid surgery affect the fallopian tubes. Specifically, this study will test if the fallopian tubes are occluded or patent (open) before and after surgically removing fibroids.
Chromopertubation is a commonly performed and well-established procedure that is done during laparoscopic surgery to determine if the fallo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients undergoing minimally invasive laparoscopic or robotic-assisted uterine-preserving gynecologic surgery for removal of uterine fibroids (myomectomy) by a minimally invasive gynecologic surgeon at MedStar.
Exclusion Criteria:
* Patients with both fallopian tubes absent…
Contacts